NO20082992L - Ostrogenmodulatorer - Google Patents
OstrogenmodulatorerInfo
- Publication number
- NO20082992L NO20082992L NO20082992A NO20082992A NO20082992L NO 20082992 L NO20082992 L NO 20082992L NO 20082992 A NO20082992 A NO 20082992A NO 20082992 A NO20082992 A NO 20082992A NO 20082992 L NO20082992 L NO 20082992L
- Authority
- NO
- Norway
- Prior art keywords
- ostrogenmodulatorer
- isoxazoles
- present application
- application relates
- new class
- Prior art date
Links
- 229940011871 estrogen Drugs 0.000 abstract 1
- 239000000262 estrogen Substances 0.000 abstract 1
- 150000002545 isoxazoles Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75278005P | 2005-12-22 | 2005-12-22 | |
| US80523306P | 2006-06-20 | 2006-06-20 | |
| PCT/IB2006/003671 WO2007072164A2 (fr) | 2005-12-22 | 2006-12-11 | Modulateurs d'oestrogenes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20082992L true NO20082992L (no) | 2008-09-22 |
Family
ID=38066616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20082992A NO20082992L (no) | 2005-12-22 | 2008-07-02 | Ostrogenmodulatorer |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US7470715B2 (fr) |
| EP (1) | EP1966170A2 (fr) |
| JP (1) | JP2009520808A (fr) |
| KR (1) | KR20080073346A (fr) |
| AP (1) | AP2008004481A0 (fr) |
| AR (1) | AR058611A1 (fr) |
| AU (1) | AU2006327877A1 (fr) |
| BR (1) | BRPI0620215A2 (fr) |
| CA (1) | CA2628596A1 (fr) |
| EA (1) | EA200801407A1 (fr) |
| EC (1) | ECSP088533A (fr) |
| NL (1) | NL2000351C2 (fr) |
| NO (1) | NO20082992L (fr) |
| PE (1) | PE20070815A1 (fr) |
| RS (1) | RS20080267A (fr) |
| UY (1) | UY30047A1 (fr) |
| WO (1) | WO2007072164A2 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2013001612A (es) * | 2010-08-10 | 2013-07-05 | Abbvie Inc | Moduladores de trpv3 novedosos. |
| CN111938907B (zh) * | 2020-08-12 | 2022-07-01 | 中国人民解放军陆军军医大学第一附属医院 | 一种鼻部手术后外敷面罩 |
| GB2608397B (en) * | 2021-06-29 | 2025-04-09 | Chaitowitz Ilan | Gynecomastia treatment |
Family Cites Families (71)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US171412A (en) * | 1875-12-21 | Improvement in buck-boards | ||
| US256210A (en) * | 1882-04-11 | Bodolphe t | ||
| US525666A (en) * | 1894-09-04 | Axel sarnmark | ||
| US9799A (en) * | 1853-06-21 | Simon ikgeksoll | ||
| US207927A (en) * | 1878-09-10 | Improvement in horse hay-rakes | ||
| GB1012182A (en) | 1963-04-23 | 1965-12-08 | Ass Portland Cement | Improvement in the manufacture of hydraulic cement |
| JPS63108339A (ja) | 1986-10-27 | 1988-05-13 | Fuji Photo Film Co Ltd | ハロゲン化銀カラ−感光材料の処理方法 |
| GB2201672A (en) | 1986-12-18 | 1988-09-07 | Shell Int Research | Diphenyl ether compounds |
| US4952700A (en) | 1988-04-25 | 1990-08-28 | W.R. Grace & Co.-Conn. | Preparation of isoxazolines and isoxazoles |
| US4933464A (en) * | 1988-04-25 | 1990-06-12 | W. R. Grace & Co.-Conn. | Process for forming 3-phenylisoxazolines and 3-phenylisoxazoles |
| JPH089599B2 (ja) | 1988-08-02 | 1996-01-31 | 三井東圧化学株式会社 | ピラゾールカルボン酸類の製造方法 |
| JPH089600B2 (ja) | 1988-08-02 | 1996-01-31 | 三井東圧化学株式会社 | ピラゾールカルボン酸類の製造方法 |
| IT1228288B (it) | 1989-01-09 | 1991-06-07 | Zambon Spa | Composti ad attivita' antiserotoninica |
| DE4016049A1 (de) * | 1990-05-18 | 1991-11-21 | Basf Ag | 3-isoxazolylbenzylester, ihre herstellung und ihre verwendung |
| US5256632A (en) * | 1990-05-30 | 1993-10-26 | Bayer Aktiengesellschaft | Herbicidal sulphonylated carboxamides |
| DK178590D0 (da) | 1990-07-26 | 1990-07-26 | Novo Nordisk As | 1,4-disubstituerede piperaziner |
| US5260322A (en) | 1990-10-08 | 1993-11-09 | Merck & Co., Inc. | Angiotension II antagonists in the treatment of hyperuricemia |
| JP3010387B2 (ja) | 1991-05-13 | 2000-02-21 | コニカ株式会社 | ピラゾール誘導体 |
| JP3454531B2 (ja) * | 1991-11-07 | 2003-10-06 | 三共株式会社 | ニトロキシアルキルアミド誘導体 |
| DE4137940A1 (de) | 1991-11-18 | 1993-05-19 | Basf Ag | 3-isoxazolylphenylverbindungen, ihre herstellung und ihre verwendung |
| WO1994017059A1 (fr) | 1993-01-29 | 1994-08-04 | Nippon Soda Co., Ltd. | Derive heterocyclique |
| IT1263751B (it) | 1993-02-05 | 1996-08-27 | Mini Ricerca Scient Tecnolog | Derivati di esteri arilacetici ad attivita' fungicida |
| JPH06236057A (ja) | 1993-02-10 | 1994-08-23 | Fuji Xerox Co Ltd | 電子写真感光体 |
| JPH07304748A (ja) | 1993-06-29 | 1995-11-21 | Nissan Chem Ind Ltd | アルドキシム誘導体および農園芸用殺菌剤 |
| WO1995011896A1 (fr) | 1993-10-26 | 1995-05-04 | Nissan Chemical Industries, Ltd. | Derive de pyrazole substitue, et fongicide agricole et horticole |
| JP3791015B2 (ja) | 1994-03-31 | 2006-06-28 | 日産化学工業株式会社 | スルホンアミド誘導体の製造方法 |
| JP3329061B2 (ja) | 1994-04-19 | 2002-09-30 | 三菱化学株式会社 | 電子写真用感光体 |
| JPH0873436A (ja) | 1994-07-06 | 1996-03-19 | Nissan Chem Ind Ltd | セミカルバゾン誘導体 |
| US5486534A (en) | 1994-07-21 | 1996-01-23 | G. D. Searle & Co. | 3,4-substituted pyrazoles for the treatment of inflammation |
| FR2725988B1 (fr) | 1994-10-24 | 1997-01-24 | Roussel Uclaf | Nouveaux derives de pyrazolones et pyrazoles acides, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant |
| CN1117080A (zh) | 1995-01-11 | 1996-02-21 | 刘波 | 苏云金芽胞杆菌培养基 |
| BR9607035A (pt) * | 1995-02-13 | 1997-11-04 | Searle & Co | Isoxazois substituidos para o tratamento de inflamação |
| WO1996033994A1 (fr) | 1995-04-28 | 1996-10-31 | Nippon Soda Co., Ltd. | Derives amino-substitues, leur procede de preparation et herbicide |
| ES2247604T3 (es) * | 1995-06-12 | 2006-03-01 | G.D. SEARLE & CO. | Composiciones que comprenden un inhibidor de ciclooxigenasa-2 y un inhibidor de 5-lipoxigenasa. |
| BR9611047A (pt) | 1995-10-17 | 2000-03-08 | Searle & Co | Processo de deteção de ciclo oxigenase-2 |
| DK0880363T3 (da) | 1996-02-13 | 2003-01-20 | Searle & Co | Kombinationer der omfatter en cyclooxygenase-2 hæmmer samt en leukotrien A4 hydrolasehæmmer, som har immunsuppressive virkninger |
| ATE233743T1 (de) | 1996-04-12 | 2003-03-15 | Searle & Co | N-((4-(5-methyl-3-phenylisoxazol-4- yl)phenyl)sulphonylpropylamid und sein natriumsalz als pro-pharmakon von cox-2 inhibitoren |
| JP3399756B2 (ja) * | 1996-10-22 | 2003-04-21 | 三菱製紙株式会社 | 平版印刷版の処理方法 |
| BR9812041B1 (pt) * | 1997-09-05 | 2009-08-11 | processo para a preparação de derivados n-acilados (hetero) aromáticos da hidroxilamina. | |
| US5972986A (en) * | 1997-10-14 | 1999-10-26 | G.D. Searle & Co. | Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia |
| CA2372912C (fr) | 1997-10-14 | 2008-12-02 | G.D. Searle & Co. | Application d'inhibiteurs de la cyclogenase-2 au traitement et a la prevention du processus neoplasique |
| JPH11124306A (ja) | 1997-10-22 | 1999-05-11 | Nissan Chem Ind Ltd | 殺虫・殺ダニ・殺菌剤組成物 |
| EP1102755B1 (fr) * | 1998-08-07 | 2006-01-04 | Chiron Corporation | Isoxazoles substitues comme modulateurs de recepteur d'oestrogenes |
| AU1199600A (en) | 1998-10-02 | 2000-04-26 | Board Of Trustees Of The University Of Illinois, The | Estrogen receptor ligands |
| AU766648B2 (en) * | 1999-03-17 | 2003-10-23 | Axys Pharmaceuticals, Inc. | Compounds and methods for modulation of estrogen receptors |
| AU3253800A (en) | 1999-05-14 | 2000-11-16 | Pfizer Products Inc. | Combination therapy for the treatment of migraine |
| US6413965B1 (en) | 1999-06-30 | 2002-07-02 | Pfizer Inc. | Compositions and treatment for diabetic complications |
| CO5190678A1 (es) | 1999-06-30 | 2002-08-29 | Pfizer Prod Inc | Terapia combinada para el tratamiento de la migrana |
| JP4645871B2 (ja) | 1999-09-24 | 2011-03-09 | 日本農薬株式会社 | イソキサゾリン誘導体及び除草剤並びにその使用方法 |
| PT1254135E (pt) | 1999-12-02 | 2005-03-31 | Novartis Ag | Compostos organicos |
| AU2001255600A1 (en) | 2000-04-25 | 2001-11-07 | Pharmacia Corporation | Regioselective synthesis of 3,4-di(carbocyclyl or heterocyclyl)thiophenes |
| JP2001302662A (ja) | 2000-04-27 | 2001-10-31 | Nissan Chem Ind Ltd | アクリロニトリル化合物 |
| EP1339683B1 (fr) | 2000-11-27 | 2006-06-14 | Merck & Co., Inc. | Modulateurs de recepteurs d'oestrogenes |
| US6693295B2 (en) * | 2000-12-25 | 2004-02-17 | Fuji Photo Film Co., Ltd. | Indole derivative, material for light-emitting device and light-emitting device using the same |
| US7276523B2 (en) | 2001-03-30 | 2007-10-02 | Smithkline Beecham Corporation | Aminopyridine derivatives as estrogen receptor modulators |
| US6673818B2 (en) | 2001-04-20 | 2004-01-06 | Pharmacia Corporation | Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation |
| EP1270535A3 (fr) * | 2001-06-20 | 2004-02-18 | Clariant GmbH | Méthode de préparation de composés aromatiques substitués |
| US6884814B2 (en) | 2001-12-13 | 2005-04-26 | Wyeth | Phenyl benzisoxazoles as estrogenic agents |
| US6960607B2 (en) | 2001-12-13 | 2005-11-01 | Wyeth | Naphthyl benzoxazoles and benzisoxazoles as estrogenic agents |
| GB0130339D0 (en) | 2001-12-19 | 2002-02-06 | Lilly Co Eli | Isochroman compounds |
| ATE374753T1 (de) | 2001-12-21 | 2007-10-15 | Vernalis Cambridge Ltd | 3-(2,4)dihydroxyphenyl-4-phenylpyrazole und deren medizinische verwendung |
| WO2003057215A1 (fr) | 2001-12-28 | 2003-07-17 | Takeda Chemical Industries, Ltd. | Accelerateur de production/secretion de facteur neurotrophique |
| US6803379B2 (en) * | 2002-06-04 | 2004-10-12 | Jose A. Fernandez-Pol | Pharmacological agents and methods of treatment that inactivate pathogenic prokaryotic and eukaryotic cells and viruses by attacking highly conserved domains in structural metalloprotein and metalloenzyme targets |
| DK1606307T3 (da) | 2002-07-03 | 2008-01-21 | Ortho Mcneil Pharm Inc | Östrieno(3,2-b)/(3,4-b)pyrrolderivater egnede som modulatorer for östrogenreceptorer |
| JP2006508927A (ja) | 2002-09-19 | 2006-03-16 | メルク エンド カムパニー インコーポレーテッド | エストロゲン受容体修飾因子 |
| CA2512000C (fr) | 2002-12-26 | 2011-08-09 | Eisai Co., Ltd. | Modulateurs selectifs des recepteurs d'oestrogene |
| WO2004073610A2 (fr) | 2003-02-13 | 2004-09-02 | Merck & Co., Inc. | Modulateurs des recepteurs des oestrogenes |
| WO2004073612A2 (fr) | 2003-02-13 | 2004-09-02 | Merck & Co. Inc. | Modulateurs de recepteur d'oestrogenes |
| US7183445B2 (en) | 2003-05-31 | 2007-02-27 | Janssen Pharmaceutica N.V | Cyclohexyl derivatives as selective estrogen receptor modulators |
| EP1692127B1 (fr) | 2003-10-08 | 2008-07-02 | Smithkline Beecham Corporation | Composes de triphenylethylene comme modulateurs selectifs du recepteur des oestrogenes |
| KR20070028400A (ko) | 2004-05-04 | 2007-03-12 | 아카디아 파마슈티칼스 인코포레이티드 | 에스트로겐 리셉터에 활성을 갖는 화합물 |
-
2006
- 2006-12-04 NL NL2000351A patent/NL2000351C2/nl not_active IP Right Cessation
- 2006-12-11 JP JP2008546673A patent/JP2009520808A/ja active Pending
- 2006-12-11 CA CA002628596A patent/CA2628596A1/fr not_active Abandoned
- 2006-12-11 WO PCT/IB2006/003671 patent/WO2007072164A2/fr not_active Ceased
- 2006-12-11 AU AU2006327877A patent/AU2006327877A1/en not_active Abandoned
- 2006-12-11 RS RSP-2008/0267A patent/RS20080267A/sr unknown
- 2006-12-11 EA EA200801407A patent/EA200801407A1/xx unknown
- 2006-12-11 BR BRPI0620215-2A patent/BRPI0620215A2/pt not_active Application Discontinuation
- 2006-12-11 KR KR1020087015099A patent/KR20080073346A/ko not_active Ceased
- 2006-12-11 AP AP2008004481A patent/AP2008004481A0/xx unknown
- 2006-12-11 EP EP06842247A patent/EP1966170A2/fr not_active Withdrawn
- 2006-12-19 US US11/612,582 patent/US7470715B2/en not_active Expired - Fee Related
- 2006-12-20 PE PE2006001664A patent/PE20070815A1/es not_active Application Discontinuation
- 2006-12-20 UY UY30047A patent/UY30047A1/es not_active Application Discontinuation
- 2006-12-21 AR ARP060105717A patent/AR058611A1/es unknown
-
2008
- 2008-06-12 EC EC2008008533A patent/ECSP088533A/es unknown
- 2008-07-02 NO NO20082992A patent/NO20082992L/no not_active Application Discontinuation
- 2008-10-31 US US12/262,565 patent/US20090131397A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| NL2000351C2 (nl) | 2007-09-11 |
| EA200801407A1 (ru) | 2008-10-30 |
| BRPI0620215A2 (pt) | 2011-11-01 |
| JP2009520808A (ja) | 2009-05-28 |
| UY30047A1 (es) | 2007-07-31 |
| US20070149564A1 (en) | 2007-06-28 |
| ECSP088533A (es) | 2008-07-30 |
| AP2008004481A0 (en) | 2008-06-30 |
| CA2628596A1 (fr) | 2007-06-28 |
| US20090131397A1 (en) | 2009-05-21 |
| AR058611A1 (es) | 2008-02-13 |
| WO2007072164A3 (fr) | 2007-10-04 |
| AU2006327877A1 (en) | 2007-06-28 |
| NL2000351A1 (nl) | 2007-06-25 |
| EP1966170A2 (fr) | 2008-09-10 |
| KR20080073346A (ko) | 2008-08-08 |
| WO2007072164A2 (fr) | 2007-06-28 |
| US7470715B2 (en) | 2008-12-30 |
| RS20080267A (sr) | 2009-05-06 |
| PE20070815A1 (es) | 2007-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20091395L (no) | Nye tiofenderivater | |
| NO20075693L (no) | Modulerende forbindelser av indolamin-2,3-dioksygenase og fremgangsmater for anvendelse av samme | |
| NO20055135D0 (no) | Fenylguinoliner og deres anvendelse som ostrogenreseptormodulatorer | |
| DK1660491T3 (da) | Benzimidazol-, benzthiazol- og benzoxazolderivater og deres anvendelse som LTA4Hmodulatorer | |
| DK1789401T3 (da) | Isoxazolinderivater og deres anvendelse som herbicider | |
| CY1110491T1 (el) | Διαμορφωτες του υποδοχεα γλυκοκορτικοειδους αζαδεκαλινης | |
| DK1594867T3 (da) | Phenylacetamider og deres anvendelse som glucokinasemodulatorer | |
| CR11548A (es) | Azolilmetiloxiranos, su uso y agentes que los contienen | |
| EA200900781A1 (ru) | 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и циклогексантрионы, как новые гербициды | |
| NO20090994L (no) | 2-aminobenzoxazol karboxamider som 5HT3 modulatorer | |
| NO20076001L (no) | Tigecyklin og metoder for deres fremstilling | |
| CL2008000873A1 (es) | Compuestos derivados de pirrolidin amidas; composicion farmaceutica que comprende dichos compuestos; y su uso para tratar trombosis. | |
| NO20084852L (no) | MGLUR5 modulatorer V | |
| CL2008002041A1 (es) | Compuestos derivados de piperidina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar ansiedad. | |
| BRPI0518752A2 (pt) | 1-alquinil-2-arilàxi-alquil-amidas e uso do mesmo como fungicidas | |
| DK1928840T3 (da) | 1H-pyrazol-4-carboxamider, deres fremstilling og deres anvendelse som 11-beta-hydroxysteroid-dehydrogenaseinhibitorer | |
| DK1636228T3 (da) | Nye pyridopyraziner og deres anvendelse som kinasemodulatorer | |
| AR059444A1 (es) | Composiciones ramnolipidicas y metodos de uso relacionados | |
| DK1799649T3 (da) | 3-(2-hydroxyphenyl)-pyrazoler og deres anvendelse som hsp90-modulatorer | |
| CR11157A (es) | Derivados de 7-alquinil-1,8-naftiridonas, su preparacion y su aplicacion en terapeutica | |
| CL2009000665A1 (es) | Compuestos derivados de pirrolidinilo; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de la ansiedad, depresion o ambas. | |
| EA200900780A1 (ru) | Аналоги эпотилона, модифицированные в положениях c12-c13, как противораковые лекарственные средства | |
| NO20084290L (no) | Process to prepare sulfonyl chloride derivatives | |
| NO20064053L (no) | Androgen reseptormodulatorer | |
| NO20076026L (no) | Adrogenmodulatorer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |